Opsens participates in Goldman Sachs Emerging Healthcare Series highlights FFR market and Company's technology

QUEBEC CITY, April 19, 2013 /CNW Telbec/ - Opsens Inc. ("Opsens") (TSXV: OPS) is pleased to announce that the Company participated to the most recent Emerging Healthcare Series hosted by Goldman Sachs.   As part of the presentation, Louis Laflamme, CEO, discussed the market for fractional flow reserve (FFR), the Company's technology and competitive advantages as well as the commercial outlook for this business segment. Interested parties can access a replay of this call until April 29, 2013 at 1-800-332-6854 with code #879632.

"We are very pleased to present at Goldman Sachs and appreciated the venue afforded to us to discuss the promising market opportunities for a third player in the fast-growing FFR market.  The Company has made significant progress towards our goal of providing our FFR product line worldwide and we look forward to detailing further updates to our shareholders throughout the year," stated Louis Laflamme, CEO.

About Opsens Inc. (www.opsens.com)

Opsens is a leading developer, manufacturer, supplier and installer of a wide range of fiber optic solutions based on proprietary patented technologies for the measurement of pressure, temperature and other parameters. The qualities of our sensors allow us to offer measuring instruments that are effective and durable in extreme conditions. Opsens is using its competitive advantages to focus primarily on two strong growth markets: oil and gas and FFR medical instrumentation.

Neither TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.

Forward-looking statements contained in this press release involve known and unknown risks, uncertainties and other factors that may cause actual results, performance and achievements of Opsens to be materially different from any future results, performance or achievements expressed or implied by the said forward-looking statements.

SOURCE: OPSENS INC.